- Acute sinusitis, an inflammation of the sinuses typically caused by infections or allergens, is a common medical condition that significantly impacts patient quality of life and drives considerable healthcare visits globally. It is managed through a combination of diagnostic imaging, pharmacological treatments, and, in severe cases, surgical interventions, with a growing emphasis on early diagnosis and outpatient care.
- The increasing demand for acute sinusitis treatment is largely driven by the rising prevalence of upper respiratory tract infections, especially in urban areas with high pollution levels and changing climate patterns. Additionally, increased awareness, improved healthcare access, and advancements in ENT diagnostic technology are contributing to earlier detection and more efficient management of the condition.
- North America leads the global acute sinusitis market, accounting for the largest revenue share of 38.6% in 2025, attributed to the region's well-established healthcare infrastructure, high patient awareness levels, and widespread use of advanced diagnostic tools such as nasal endoscopy and CT imaging. The U.S. dominates within the region, driven by frequent outpatient ENT visits and high adoption of combination drug therapies.
- Asia-Pacific is expected to register the fastest growth in the acute sinusitis market during the forecast period due to increasing healthcare investments, rising pollution-related respiratory conditions, and expanding access to ENT care in countries like China and India.
- The medication segment is projected to dominate the market with a market share of 56.4% in 2025, owing to the widespread use of antibiotics, nasal corticosteroids, antihistamines, and decongestants for non-invasive and cost-effective treatment. The diagnosis segment, meanwhile, is witnessing growth due to enhanced ENT imaging and diagnostic precision.
